Skip to main content
. 2020 Aug 12;11:1872. doi: 10.3389/fmicb.2020.01872

Figure 1.

Figure 1

Determinants of on‐ and off-target activity of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) based therapeutics. The two main components of the CRISPR/Cas9 system are the Cas9 endonuclease and the guide RNA (gRNA). Specific structural alterations of these components have been shown to enhance the on-target excision rate and/or reduce the off-target excision rate. Here, we present some of the factors that influence these excision rates.